|
Specialised palliative care team consulted
|
0
|
22/967
|
2.3
|
192/15,495
|
1.2
|
0.006
|
|
Documented decision to shift to end-of-life care
|
1754
|
731/897
|
81.5
|
12,460/13,811
|
90.2
|
< 0.001
|
|
Next of kin given information about transition to end-of-life care
|
1284
|
714/878
|
81.3
|
10,215/14,300
|
71.4
|
< 0.001
|
|
Next of kin offered a follow-up talk after death of the patient
|
2968
|
263/617
|
42.6
|
9697/12,877
|
75.3
|
< 0.001
|
|
Pain assessed and documented during the last week of life
|
619
|
140/861
|
16.3
|
4838/14,982
|
32.3
|
< 0.001
|
|
Symptoms other than pain assessed during the last week of life
|
853
|
79/802
|
9.9
|
2773/14,807
|
18.7
|
< 0.001
|
|
Oral health assessed during the last week of life
|
1280
|
630/824
|
76.5
|
10,992/14,358
|
76.6
|
0.947
|
|
Prescription of PRN drugs against pain
|
62
|
839/949
|
88.4
|
14,461/15,451
|
93.6
|
< 0.001
|
|
Prescription of PRN drugs against nausea
|
225
|
398/927
|
42.9
|
9606/15,310
|
62.7
|
< 0.001
|
|
Prescription of PRN drugs against anxiety
|
133
|
705/939
|
75.1
|
13,171/15,390
|
85.6
|
< 0.001
|
|
Pressure ulcer at death
|
157
|
219/908
|
24.1
|
2278/15,397
|
14.8
|
< 0.001
|
|
Someone present at the moment of death
|
291
|
652/936
|
69.7
|
13,711/15,235
|
90.0
|
< 0.001
|
|
Fluids via enteral tube or intravenously during last 24 h of life
|
55
|
344/943
|
36.5
|
220/15,464
|
1.4
|
< 0.001
|
